Cargando…
4’-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses
Influenza outbreaks are associated with substantial morbidity, mortality and economic burden. Next generation antivirals are needed to treat seasonal infections and prepare against zoonotic spillover of avian influenza viruses with pandemic potential. Having previously identified oral efficacy of th...
Autores principales: | Lieber, Carolin M., Aggarwal, Megha, Yoon, Jeong-Joong, Cox, Robert M., Kang, Hae-Ji, Sourimant, Julien, Toots, Mart, Johnson, Scott K., Jones, Cheryl A., Sticher, Zachary M., Kolykhalov, Alexander A., Saindane, Manohar T., Tompkins, Stephen M., Planz, Oliver, Painter, George R., Natchus, Michael G., Sakamoto, Kaori, Plemper, Richard K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138230/ https://www.ncbi.nlm.nih.gov/pubmed/37068076 http://dx.doi.org/10.1371/journal.ppat.1011342 |
Ejemplares similares
-
4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication
por: Sourimant, Julien, et al.
Publicado: (2021) -
Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase
por: Sourimant, Julien, et al.
Publicado: (2022) -
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
por: Lieber, Carolin M., et al.
Publicado: (2022) -
Orally Efficacious Broad-Spectrum Allosteric Inhibitor of Paramyxovirus Polymerase
por: Cox, Robert M, et al.
Publicado: (2020) -
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
por: Cox, Robert M., et al.
Publicado: (2023)